Centessa Pharmaceuticals CNTA Q1 2026 Earnings EPS Miss Amid PreRevenue Phase Stock Slips Slightly Dole Q1 2026 Earnings EPS Misses Expectations by 34 Shares Edge Lower ST Q1 2026 Earnings EPS Slightly Exceeds Estimates Stock Gains EVER Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction PONY Q1 2026 Earnings EPS Beat Driven by Cost Discipline Shares Rise WEC Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response